These compounds may interact with:
P2Y purinoceptor 12
Potentially involved in: carcinoma; coronary artery disease; cerebrovascular disease; atrial fibrillation; peripheral artery disease; diabetes mellitus; transient cerebral ischemia; limb ischemia; hemorrhage; lupus erythematosus, systemic; myocardial infarction; thrombosis; drug metabolism, poor, cyp2c19-related; bleeding disorder due to p2ry12 defect; platelet-type bleeding disorder 8; adrenocortical carcinoma; astrocytoma, pilocytic; atypical teratoid / rhabdoid tumor; breast cancer; ductal carcinoma in situ
Disease data sourced from Pharos.